In 2019, the biosimilars industry in Japan was estimated to stand at around 47 billion Japanese yen. The market was forecasted to reach approximately 115 billion Japanese yen by 2023, up from about 21.5 billion yen in 2018.
Market size of the biosimilars industry in Japan from 2018 to 2019 with a forecast for 2023 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Biopharmaceutical market size forecast Japan 2011-2020
- Net result of pharmaceutical companies in Italy 2016-2018
- Market revenue from type 2 diabetes pharmaceuticals by region 2012-2022
- Peak sales per new biopharmaceutical asset 2010-2020
- Pharma revenue share forecast worldwide for 2060, by country
- Pharma revenue share worldwide 2017, by country
- World pharmaceutical select subsector value share 2017
- Pharmaceutical expenditure forecast worldwide by country 2030
- Operating result of pharmaceutical companies in Italy 2016-2018
- Average price of patented pharmaceuticals in Italy 2010-2020
- Number of employees of pharmaceutical companies in Italy 2016-2018
- Comparison ASP of Remicade vs biosimilars in the U.S. Q3 2020
- Value share of pharma market worldwide 2015 vs. 2021, by subsector
- Factors impacting valuation of biopharma companies per executives 2020
Fuji Keizai Group. (April 20, 2020). Market size of the biosimilars industry in Japan from 2018 to 2019 with a forecast for 2023 (in billion Japanese yen) [Graph]. In Statista. Retrieved May 21, 2022, from https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/
Fuji Keizai Group. "Market size of the biosimilars industry in Japan from 2018 to 2019 with a forecast for 2023 (in billion Japanese yen)." Chart. April 20, 2020. Statista. Accessed May 21, 2022. https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/
Fuji Keizai Group. (2020). Market size of the biosimilars industry in Japan from 2018 to 2019 with a forecast for 2023 (in billion Japanese yen). Statista. Statista Inc.. Accessed: May 21, 2022. https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/
Fuji Keizai Group. "Market Size of The Biosimilars Industry in Japan from 2018 to 2019 with a Forecast for 2023 (in Billion Japanese Yen)." Statista, Statista Inc., 20 Apr 2020, https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/
Fuji Keizai Group, Market size of the biosimilars industry in Japan from 2018 to 2019 with a forecast for 2023 (in billion Japanese yen) Statista, https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/ (last visited May 21, 2022)